NCT06933758 Temple Health Chest Initiative (THCI 2.0)
| NCT ID | NCT06933758 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Temple University |
| Condition | Chronic Obstructive Pulmonary Disease (COPD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-02-28 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2025-02-28 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT screening for lung cancer in patients aged 50- 80 with ≥ 20 pack year smoking has been shown to improve survival. COPD is highly prevalent within LCS programs, with estimated rates of obstructive lung function of up to 59% and evidence of emphysema on CT scan in around 70%.
Eligibility Criteria
Inclusion Criteria: * 50 to 80 years old * Screened for early lung cancer using low dose CT imaging Exclusion Criteria: * Under 50; over 80 years old * No lung cancer screening
Contact & Investigator
Gerard Criner, MD
PRINCIPAL INVESTIGATOR
Temple University
Frequently Asked Questions
Who can join the NCT06933758 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Chronic Obstructive Pulmonary Disease (COPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06933758 currently recruiting?
Yes, NCT06933758 is actively recruiting participants. Contact the research team at lauren.e.miller@temple.edu for enrollment information.
Where is the NCT06933758 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06933758 clinical trial?
NCT06933758 is sponsored by Temple University. The principal investigator is Gerard Criner, MD at Temple University. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.